@doctorsood: The FDA has just approved a new non-opioid pain medication, marking a huge step in pain management. The FDA just approved Journavx (suzetrigine), the first non-opioid pain medication in a brand-new drug class. It treats moderate to severe acute pain without targeting opioid receptors—helping reduce opioid use and addiction risk. 🔬 What This Means: ✅ A new option for post-surgical and injury-related pain ✅ Potentially reduce opioid prescriptions and their risks when appropriate ✅ FDA fast-tracked approval due to its promising benefits ⚠️ Side effects include itching, muscle spasms, and rash. Avoid grapefruit while taking it. Let me know your thoughts in the comments. ⬇️ #painmeds #chronicpain #medical #health